News tagged with company
Related topics: initial public offering , google , stock , chief executive , securities and exchange commission
Russia parliament votes to ban smoking in public places
Russian lawmakers on Tuesday passed on third and final reading a bill banning smoking in public places, a major pillar of a Kremlin drive to improve health in the nicotine-addicted country.
Addiction
Feb 12, 2013 |
not rated yet |
0
Researchers find new clue to clinical trial failures of MMP cancer therapies
Proposed cancer therapeutic drugs based on blocking the catalytic activities of matrix metalloproteinases (MMPs), which profoundly remodel the environment surrounding a breast cell, have performed poorly ...
Cancer
Feb 12, 2013 |
not rated yet |
0
First-in-man study demonstrates the therapeutic effect of RNAi gene silencing in cancer treatment
A study led by Dr Josep Tabernero, the Director of Clinical Research at the Vall d'Hebron Institute of Oncology (VHIO) and Head of the Medical Oncology Department at the Vall d'Hebron University Hospital, shows for the first ...
Cancer
Feb 11, 2013 |
5 / 5 (2) |
0
Rivaroxaban found noninferior to enoxaparin in acutely ill
(HealthDay)—In acutely ill hospitalized patients, standard-duration rivaroxaban has similar efficacy as enoxaparin in reducing the risk of venous thromboembolism, while extended-duration rivaroxaban has ...
Diseases, Conditions, Syndromes
Feb 07, 2013 |
not rated yet |
0
Spanish researchers design biomarkers for the detection of dengue and West Nile virus
Researchers at the University of Granada have designed a set of biomarkers that can be used in diagnostic tests for the detection of dengue and the West Nile virus, two infectious diseases transmitted by ...
Medical research
Feb 06, 2013 |
not rated yet |
0
Icon to buy division of Cross Country Healthcare
Icon PLC plans to buy the clinical trial services division of Cross Country Healthcare Inc. in a deal potentially worth more than $55 million, as the Irish company seeks to grow globally and improve its drug safety consulting.
Other
Feb 04, 2013 |
not rated yet |
0
New report: State action on Affordable Care Act's 2014 health insurance market reforms
Only 11 states and the District of Columbia have passed laws or issued regulations to implement the Affordable Care Act's major health insurance market reforms that go into effect in 2014, according to a new Commonwealth ...
Health
Feb 01, 2013 |
not rated yet |
0
Danish Novo Nordisk profit surges
Danish pharmaceutical company Novo Nordisk A/S on Thursday reported a 23 percent growth in fourth-quarter net profit on strong sales of diabetic drugs and gave a positive outlook as regulators worldwide begin to approve its ...
Other
Jan 31, 2013 |
not rated yet |
0
AstaZeneca in patent warning as net profit falls
(AP)—Anglo-Swedish pharmaceutical company AstraZeneca PLC warned over expiring patents on its medicines as the company announced a 37 percent fall in full-year net profit on Thursday.
Other
Jan 31, 2013 |
not rated yet |
0
Linagliptin: Once again, no proof of added benefit
Linagliptin (trade name Trajenta) has been approved since August 2011 to improve blood glucose control in adults with type 2 diabetes. The assessment of the new dossier according to the German Act on the Reform of the Market ...
Medications
Jan 30, 2013 |
not rated yet |
0
Perampanel for epilepsy: No proof of added benefit
The drug perampanel (trade name Fycompa) has been approved since July 2012 as adjunctive ("add-on") therapy for adults and children aged 12 years and older with epileptic fits (seizures). In an early benefit assessment according ...
Medications
Jan 30, 2013 |
not rated yet |
0
Greater transparency needed in publishing information from clinical trials
An initiative from the drugs regulator, the European Medicines Agency, to commit to releasing all of the information from clinical trials once the marketing authorization process has ended, which has been greeted with cautious ...
Other
Jan 29, 2013 |
not rated yet |
0
Discrepant analyses of industry-sponsored clinical trials
Discrepancies between internal and published analyses of industry-sponsored clinical trials lead to further calls for transparency
Other
Jan 29, 2013 |
not rated yet |
0
FDA warns company over unapproved flu remedy
Federal regulators say a Florida company has been marketing an untested inhaled formula as a flu remedy in violation of drug safety regulations.
Medications
Jan 29, 2013 |
not rated yet |
0
Botox offers hope to women with incontinence
When most people hear Botox, they think of injections to the face to combat wrinkles and aging.
Diseases, Conditions, Syndromes
Jan 29, 2013 |
not rated yet |
0
